I. Klein

805 total citations
16 papers, 668 citations indexed

About

I. Klein is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, I. Klein has authored 16 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in I. Klein's work include Chemotherapy-induced organ toxicity mitigation (11 papers), Metal complexes synthesis and properties (9 papers) and Drug Transport and Resistance Mechanisms (4 papers). I. Klein is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (11 papers), Metal complexes synthesis and properties (9 papers) and Drug Transport and Resistance Mechanisms (4 papers). I. Klein collaborates with scholars based in Netherlands, Hungary and Belgium. I. Klein's co-authors include W. J. F. van der Vijgh, Herbert M. Pinedo, F. Elferink, H.E. Gall, Jacobus Klootwijk, W J van der Vijgh, Jan B. Vermorken, J. B. Vermorken, Les Grivell and A. A. M. Hart and has published in prestigious journals such as Journal of Molecular Biology, Analytical Biochemistry and British Journal of Cancer.

In The Last Decade

I. Klein

16 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I. Klein Netherlands	12	275	228	220	107	76	16	668
F. Elferink Netherlands	9	161 0.6×	75 0.3×	113 0.5×	81 0.8×	64 0.8×	14	369
C E Pfeifle United States	13	259 0.9×	93 0.4×	189 0.9×	306 2.9×	169 2.2×	23	776
Ellen Scheiner United States	7	256 0.9×	105 0.5×	221 1.0×	166 1.6×	26 0.3×	12	677
G. Lelli Italy	13	368 1.3×	167 0.7×	78 0.4×	266 2.5×	89 1.2×	46	876
R Z Arzoomanian United States	10	255 0.9×	326 1.4×	41 0.2×	56 0.5×	29 0.4×	14	744
Dava J. Garcia United States	9	144 0.5×	134 0.6×	53 0.2×	83 0.8×	56 0.7×	16	448
Connie Marcus United States	7	288 1.0×	95 0.4×	56 0.3×	23 0.2×	40 0.5×	8	570
Maria O. Vannozzi Italy	15	261 0.9×	125 0.5×	148 0.7×	62 0.6×	12 0.2×	34	692
JHM Schellens Netherlands	12	448 1.6×	412 1.8×	78 0.4×	55 0.5×	17 0.2×	16	626
Myers Ce United States	8	119 0.4×	171 0.8×	43 0.2×	102 1.0×	44 0.6×	14	516

Countries citing papers authored by I. Klein

Since Specialization

Citations

This map shows the geographic impact of I. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Klein more than expected).

Fields of papers citing papers by I. Klein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Klein. The network helps show where I. Klein may publish in the future.

Co-authorship network of co-authors of I. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of I. Klein. A scholar is included among the top collaborators of I. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Klein. I. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Schwartsmann, Gilberto, W. J. F. van der Vijgh, I. Klein, et al.. (1989). Pharmacokinetics of Brequinar sodium (NSC 368390) in patients with solid tumors during a phase I study. European Journal of Cancer and Clinical Oncology. 25(12). 1675–1681. 16 indexed citations

Elferink, F., W. J. F. van der Vijgh, I. Klein, et al.. (1988). Pharmacokinetics of carboplatin after intraperitoneal administration. Cancer Chemotherapy and Pharmacology. 21(1). 57–60. 77 indexed citations

Vijgh, W. J. F. van der, F. Elferink, Jan B. Vermorken, et al.. (1988). Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of aqua(1,1-bis(aminomethyl)cyclohexane) sulfatoplatinum (II) (spiroplatin) during a phase I trial. European Journal of Cancer and Clinical Oncology. 24(4). 621–627. 2 indexed citations

Elferink, F., JB Vermorken, I. Klein, et al.. (1987). Pharmacokinetics of ethylenediaminemalonatoplatinum(II) (JM-40) during phase I trial. British Journal of Cancer. 56(4). 479–483. 3 indexed citations

Baumann, R. A., C. Gooijer, N.H. Velthorst, et al.. (1987). Quantitative determination of cisplatin in body fluids by liquid chromatography with quenched phosphorescence detection. Journal of Pharmaceutical and Biomedical Analysis. 5(2). 165–170. 26 indexed citations

Elferink, F., W J van der Vijgh, I. Klein, et al.. (1987). Pharmacokinetics of carboplatin after i.v. administration.. PubMed. 71(12). 1231–7. 60 indexed citations

Hegedűs, László, W. J. F. van der Vijgh, I. Klein, S. Kerpel‐Fronius, & Herbert M. Pinedo. (1987). Chemical reactivity of cisplatin bound to human plasma proteins. Cancer Chemotherapy and Pharmacology. 20(3). 211–212. 21 indexed citations

Vijgh, W J van der, I. Klein, F. Elferink, et al.. (1987). Comparative pharmacokinetics of cisplatin and three analogues in mice and humans.. PubMed. 47(23). 6297–301. 75 indexed citations

Vijgh, W. J. F. van der & I. Klein. (1986). Protein binding of five platinum compounds. Cancer Chemotherapy and Pharmacology. 18(2). 129–132. 56 indexed citations

10.

Elferink, F., W J van der Vijgh, I. Klein, & Herbert M. Pinedo. (1986). Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding.. Clinical Chemistry. 32(4). 641–645. 68 indexed citations

11.

Vijgh, W. J. F. van der, Paul C.M. Verbeek, I. Klein, & H. M. Pinedo. (1985). Biliary excretion of platinum in rats after administration of cisplatin and aqua(1,1-bis(aminomethyl)-cyclohexane)sulfatoplatinum(II) (Spiroplatin, TNO-6). Cancer Letters. 28(1). 103–109. 7 indexed citations

12.

Vermorken, Jan B., W. J. F. van der Vijgh, I. Klein, et al.. (1984). Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin.. PubMed. 68(3). 505–13. 109 indexed citations

13.

Vermorken, J. B., W. J. F. van der Vijgh, I. Klein, H.E. Gall, & Herbert M. Pinedo. (1982). Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implications. PubMed. 18(11). 1069–1074. 62 indexed citations

14.

Mager, W.H., Jacobus Klootwijk, & I. Klein. (1976). Minimal methylation of yeast messenger RNA. Molecular Biology Reports. 3(1). 9–17. 19 indexed citations

15.

Klein, I. & Jacobus Klootwijk. (1976). Determination of 2′-O-methyl groups in 32P-labeled RNAs. Analytical Biochemistry. 74(2). 263–272. 1 indexed citations

16.

Klootwijk, Jacobus, I. Klein, & Les Grivell. (1975). Minimal post-transcriptional modification of yeast mitochondrial ribosomal RNA. Journal of Molecular Biology. 97(3). 337–350. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact